Unigene Laboratories
From Wikipedia, the free encyclopedia
| Unigene Laboratories | |
|---|---|
| Type | Public |
| Founded | 1980 |
| Headquarters | |
| Key people | Warren Levy, president & CEO James Gilligan, vice president, product development |
| Industry | Biotechnology |
| Employees | 85 (2007) |
| Website | http://www.unigene.com |
Unigene Laboratories (OTC:UGNE) is a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey.
The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis. The company has licensed worldwide rights to its oral parathyroid hormone ("PTH") to GlaxoSmithKline.
